You are here: Industry Insights > Strides

News List

Strides enters into JV with Sihuan Pharma biospectrumasia
July 30, 2019
The JV fast tracks Strides’ entry into China, the second-largest pharmaceutical market in the World offering a $137 billion (IQVIA) market opportunity.
Strides announces final closure of Arrow transaction expresspharma
July 11, 2019
Strides Pharma Global has announced the closure of its transaction with Arrow. The company disclosed that it has received AUD 300 million immediately at closing, while the balance AUD 94 million will be a deferred consideration backed by a secured interes
Strides to launch Potassium Chloride Extended-Release tablets in the US market expressbpd
April 03, 2019
Product jointly developed with Pharmaceutics International, Inc to be commercialized by Strides in the US market
Strides to acquire remaining stake in Vivimed biospectrumasia
January 31, 2019
Complements Strides’s front end led growth with a de-risked manufacturing base.
Amazon joins NIH cloud computing initiative pharmaphorum
December 20, 2018
Amazon Web Services has joined a cloud computing initiative from the US National Institutes of Health.Launched in July, the NIH’s Science and Technology Research Infrastructure for Discovery.....
Strides Vivimed JV receives approval for Albendazole tabs expressbpd
December 13, 2018
The product, used to treat certain infections caused by tapeworm, will be launched immediately
Strides board approves $15 m investment in Stelis Biopharma expressbpd
November 24, 2018
The first close of the current fund raise is $35 million, of which Strides will commit $15 million and $20 million is from other existing shareholders
Strides enters into partnership with SUDA Pharma for migraine drug biospectrumasia
November 12, 2018
The product will utilize SUDA’s recently developed proprietary OroMist hydrotrope technology that significantly improves the rate of absorption.
Strides Pharma’s promoter sells stake worth ₹20 cr financialexpress
September 10, 2018
According to the block deal data available with the NSE, Abusha offloaded 4 lakh shares, amounting to 0.45 per cent stake in the firm
Strides Shasun posts Q4 FY18 and FY18 results financialexpress
May 21, 2018
Strides Shasun has announced its Q4 FY18 and FY18 results. In Q4 FY18, revenues were at ₹ 6,775 million, EBITDA at ₹ 1,005 million.

Previous page 1 2 3 4 Next page